Kellanova Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Kellanova Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2021-04-03 | 2020-03-28 | 2019-03-30 | 2018-03-31 | 2017-04-01 | 2016-04-02 | 2013-03-30 | 2012-03-31 | 2011-04-02 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| operating activities | ||||||||||||
| net income | 308,000,000 | 271,000,000 | 302,000,000 | 371,000,000 | 350,000,000 | 285,000,000 | 444,000,000 | 262,000,000 | 175,000,000 | 311,000,000 | 358,000,000 | 365,000,000 |
| adjustments to reconcile net income to operating cash flows: | ||||||||||||
| depreciation and amortization | 92,000,000 | 86,000,000 | 116,000,000 | 112,000,000 | 117,000,000 | 124,000,000 | 122,000,000 | 121,000,000 | 115,000,000 | 113,000,000 | 95,000,000 | 89,000,000 |
| impairment of property | ||||||||||||
| postretirement benefit plan expense | -6,000,000 | -18,000,000 | -15,000,000 | -68,000,000 | -39,000,000 | -38,000,000 | -47,000,000 | -56,000,000 | -28,000,000 | -4,000,000 | ||
| deferred income taxes | 68,000,000 | 29,000,000 | -6,000,000 | 17,000,000 | 8,000,000 | 7,000,000 | -1,000,000 | -67,000,000 | 11,000,000 | -53,000,000 | 6,000,000 | |
| stock compensation | 22,000,000 | 21,000,000 | 22,000,000 | 20,000,000 | 19,000,000 | 13,000,000 | 16,000,000 | 17,000,000 | 15,000,000 | |||
| other | -23,000,000 | 36,000,000 | -10,000,000 | 13,000,000 | -11,000,000 | -8,000,000 | -30,000,000 | 30,000,000 | -33,000,000 | 5,000,000 | 28,000,000 | 6,000,000 |
| postretirement benefit plan distributions | ||||||||||||
| postretirement benefit plan contributions | -12,000,000 | -22,000,000 | -5,000,000 | -2,000,000 | -6,000,000 | -5,000,000 | -19,000,000 | -24,000,000 | -17,000,000 | -31,000,000 | -25,000,000 | -178,000,000 |
| changes in operating assets and liabilities, net of acquisitions and divestitures: | ||||||||||||
| trade receivables | 16,000,000 | -173,000,000 | -110,000,000 | -155,000,000 | -194,000,000 | -229,000,000 | -175,000,000 | -192,000,000 | -201,000,000 | -142,000,000 | -168,000,000 | -301,000,000 |
| inventories | -46,000,000 | -4,000,000 | -27,000,000 | -50,000,000 | 1,000,000 | 12,000,000 | 13,000,000 | 58,000,000 | 49,000,000 | 80,000,000 | -14,000,000 | 81,000,000 |
| accounts payable | -106,000,000 | -14,000,000 | 9,000,000 | 118,000,000 | 44,000,000 | -16,000,000 | -4,000,000 | 11,000,000 | 89,000,000 | 45,000,000 | 1,000,000 | 50,000,000 |
| all other current assets and liabilities | -197,000,000 | -83,000,000 | -141,000,000 | 102,000,000 | -75,000,000 | -91,000,000 | -36,000,000 | -63,000,000 | -13,000,000 | -47,000,000 | -28,000,000 | |
| net cash from operating activities | 116,000,000 | 364,000,000 | 276,000,000 | 235,000,000 | 391,000,000 | 70,000,000 | 228,000,000 | 211,000,000 | 5,000,000 | 338,000,000 | 340,000,000 | 310,000,000 |
| investing activities | ||||||||||||
| additions to properties | -176,000,000 | -155,000,000 | -203,000,000 | -173,000,000 | -112,000,000 | -148,000,000 | -132,000,000 | -130,000,000 | -144,000,000 | -102,000,000 | -63,000,000 | -103,000,000 |
| purchases of marketable securities | -72,000,000 | |||||||||||
| sales of marketable securities | 84,000,000 | |||||||||||
| settlement of net investment hedges | -7,000,000 | 17,000,000 | ||||||||||
| net cash from investing activities | -152,000,000 | -333,000,000 | -205,000,000 | -189,000,000 | -202,000,000 | -163,000,000 | -131,000,000 | -131,000,000 | -155,000,000 | -102,000,000 | -57,000,000 | -99,000,000 |
| financing activities | ||||||||||||
| net issuances (reductions) of notes payable | 474,000,000 | 115,000,000 | 3,000,000 | 326,000,000 | 549,000,000 | 429,000,000 | 99,000,000 | 191,000,000 | -485,000,000 | -178,000,000 | ||
| issuances of long-term debt | 401,000,000 | 1,382,000,000 | 645,000,000 | |||||||||
| reductions of long-term debt | -631,000,000 | -2,000,000 | -216,000,000 | -4,000,000 | -3,000,000 | -1,000,000 | -473,000,000 | -749,000,000 | -946,000,000 | |||
| net issuances of common stock | 42,000,000 | 23,000,000 | 19,000,000 | 18,000,000 | 46,000,000 | 7,000,000 | 50,000,000 | 40,000,000 | 164,000,000 | 265,000,000 | 41,000,000 | 122,000,000 |
| cash dividends | -197,000,000 | -191,000,000 | -202,000,000 | -195,000,000 | -195,000,000 | -192,000,000 | -187,000,000 | -182,000,000 | -176,000,000 | -160,000,000 | -153,000,000 | -148,000,000 |
| net cash from financing activities | -313,000,000 | -58,000,000 | -33,000,000 | -95,000,000 | 477,000,000 | 24,000,000 | -38,000,000 | -77,000,000 | 214,000,000 | -260,000,000 | -355,000,000 | -266,000,000 |
| effect of exchange rate changes on cash and cash equivalents | -15,000,000 | -5,000,000 | 10,000,000 | 5,000,000 | -47,000,000 | 20,000,000 | 30,000,000 | 15,000,000 | -5,000,000 | -5,000,000 | 16,000,000 | 15,000,000 |
| increase in cash and cash equivalents | -364,000,000 | -32,000,000 | 48,000,000 | -44,000,000 | 619,000,000 | -49,000,000 | 89,000,000 | 18,000,000 | 59,000,000 | -40,000,000 | ||
| cash and cash equivalents at beginning of period | 694,000,000 | 274,000,000 | 299,000,000 | 435,000,000 | 397,000,000 | 321,000,000 | 281,000,000 | 280,000,000 | 251,000,000 | 281,000,000 | 460,000,000 | 444,000,000 |
| cash and cash equivalents at end of period | 330,000,000 | 242,000,000 | 347,000,000 | 391,000,000 | 1,016,000,000 | 272,000,000 | 370,000,000 | 298,000,000 | 310,000,000 | 252,000,000 | 404,000,000 | 404,000,000 |
| supplemental cash flow disclosures of non-cash investing activities: | ||||||||||||
| additions to properties included in accounts payable | 116,000,000 | 88,000,000 | 105,000,000 | 97,000,000 | 87,000,000 | 122,000,000 | 92,000,000 | 106,000,000 | ||||
| net cash provided by: | ||||||||||||
| effect of exchange rates on cash and cash equivalents | ||||||||||||
| net increase in cash and cash equivalents | ||||||||||||
| loss on russia divestiture | ||||||||||||
| distribution from postretirement benefit plan | 175,000,000 | |||||||||||
| changes in operating assets and liabilities, net of acquisitions: | ||||||||||||
| issuance of notes receivable | -5,000,000 | -20,000,000 | ||||||||||
| purchases of available for sale securities | -5,000,000 | -2,000,000 | -65,000,000 | -7,000,000 | ||||||||
| sales of available for sale securities | 5,000,000 | 5,000,000 | 5,000,000 | 7,000,000 | ||||||||
| common stock repurchases | -240,000,000 | -220,000,000 | -125,000,000 | -198,000,000 | -44,000,000 | -63,000,000 | -329,000,000 | |||||
| collateral paid on derivatives | -15,000,000 | |||||||||||
| impairment of property plant and equipment | 60,000,000 | |||||||||||
| purchase of marketable securities | -175,000,000 | |||||||||||
| repayments from notes receivable | 28,000,000 | |||||||||||
| investments in unconsolidated entities | -10,000,000 | |||||||||||
| multi-employer pension plan exit liability | ||||||||||||
| acquisition of cost method investments | -3,000,000 | |||||||||||
| collateral received on derivative instruments | 80,000,000 | |||||||||||
| acquisitions, net of cash acquired | -18,000,000 | |||||||||||
| divestiture | ||||||||||||
| debt redemption costs | ||||||||||||
| supplemental cash flow disclosures | ||||||||||||
| interest paid | 8,000,000 | 8,000,000 | 14,000,000 | 16,000,000 | 199,000,000 | |||||||
| income taxes paid | 18,000,000 | 79,000,000 | 31,000,000 | 16,000,000 | 59,000,000 | |||||||
| gain on unconsolidated entities | ||||||||||||
| collections of deferred purchase price on securitized trade receivables | ||||||||||||
| beneficial interests obtained in exchange for securitized trade receivables | ||||||||||||
| accrued income taxes | 92,000,000 | -13,000,000 | 51,000,000 | 174,000,000 | 190,000,000 | |||||||
| accrued interest expense | 48,000,000 | 12,000,000 | 49,000,000 | 44,000,000 | -16,000,000 | |||||||
| accrued and prepaid advertising and promotion | 18,000,000 | |||||||||||
| accrued salaries and wages | -71,000,000 | -113,000,000 | -65,000,000 | -70,000,000 | 25,000,000 | |||||||
| investments in unconsolidated entities, net proceeds | ||||||||||||
| venezuela remeasurement | 6,000,000 | |||||||||||
| variable-interest entity impairment | ||||||||||||
| additions to properties included in accounts payable* | 88,000,000 | |||||||||||
| accrued and prepaid advertising, promotion and trade allowances | 12,000,000 | -72,000,000 | 17,000,000 | 21,000,000 | ||||||||
| venezuela remeasurement expense | ||||||||||||
| vie deconsolidation | ||||||||||||
| net issuances of notes payable | 1,031,000,000 | |||||||||||
| decrease in cash and cash equivalents | -29,000,000 | -56,000,000 | ||||||||||
| net reductions of notes payable | -226,000,000 | |||||||||||
| changes in operating assets and liabilities: |
We provide you with 20 years of cash flow statements for Kellanova stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Kellanova stock. Explore the full financial landscape of Kellanova stock with our expertly curated income statements.
The information provided in this report about Kellanova stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.